Cooley advised AN2 Therapeutics, Inc., and Davis Polk & Wardwell advised the joint book-running managers on the offering. AN2 Therapeutics, Inc. (Nasdaq:ANTX) announced a SEC-registered follow-on...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised PROCEPT BioRobotics, and Shearman & Sterling advised the underwriters. PROCEPT BioRobotics Corporation announced a follow-on offering of 5,085,494 shares of common stock at...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale acted as counsel to MicroStrategy Incorporated; and Davis Polk & Wardwell acted as counsel to the sales agent in the offering. MicroStrategy...
You must be a Standard 1 Year member to access this content.
Goodwin and Freshfields advised argenx, while Cooley advised the representatives of the several underwriters on the offering. argenx SE closed its $1.27 billion follow-on offering. On July 19,...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the joint book-running managers in the offering. Editas Medicine, Inc. (Nasdaq: EDIT) announced the pricing of an underwritten offering of 12,500,000 shares of its...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell LLP advised Mobileye Global Inc on the offering, while Sullivan & Cromwell LLP advised the underwriters. Mobileye Global Inc., a leader of the...
You must be a Standard 1 Year member to access this content.
Cooley advised ACELYRIN, and Davis Polk advised the joint book-running managers. ACELYRIN, INC. announced its upsized initial public offering of 34,500,000 shares of common stock at...
You must be a Standard 1 Year member to access this content.
Cooley advised AN2 Therapeutics on the offering, and Davis Polk advised the sales agent. AN2 Therapeutics, Inc. announced the SEC-registered at-the-market offering of its common stock...
You must be a Standard 1 Year member to access this content.
K&L Gates advised AVITA, and Davis Polk advised the sales agent for the offering. AVITA Medical, Inc. announced the establishment of an SEC-registered at-the-market program of...
You must be a Standard 1 Year member to access this content.
DLA Piper advised Intercept Pharmaceuticals on the offering, and Davis Polk advised the sales agent involved. Intercept Pharmaceuticals, Inc. announced the SEC-registered at-the-market offering of its...
You must be a Standard 1 Year member to access this content.
Latham & Watkins is advising Revolution Medicines on the offering, and Davis Polk is advising the underwriters involved. Revolution Medicines, Inc. (Nasdaq: RVMD) has announced the...
You must be a Standard 1 Year member to access this content.
Nelson Mullins Riley & Scarborough LLP acted for Cowen on the deal. AppHarvest, Inc. (NASDAQ: APPH, APPHW), a sustainable food company, announced that it has commenced a...
You must be a Standard 1 Year member to access this content.
